News
![EMX options its polymetallic Sagvoll and Meråker projects in Norway to Lumira Energy Ltd.: https://www.irw-press.at/prcom/images/messages/2024/73149/030123EMX_EN_PRcom.002.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXYvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--066cc41df3728a2ba8ce78c4d58f1f6fcb7423b1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/030123EMX_EN_PRcom.002.png?locale=us)
EMX options its polymetallic Sagvoll and Meråker projects in Norway to Lumira Energy Ltd.
Vancouver, British Columbia, January 3, 2024 – (NYSE American: EMX; TSX Venture: EMX; Frankfurt: 6E9) – EMX Royalty Corporation (the “Company” or “EMX”) is pleased to announce the execution
![EMX optioniert seine norwegischen Projekte Sagvoll und Meråker mit mehreren Metallen an Lumira Energy Ltd.: https://www.irw-press.at/prcom/images/messages/2024/73149/030123EMX_DE_PRcom.002.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXIvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--80866ded4e999cd981866ac7544c46f5426b0a91/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/030123EMX_DE_PRcom.002.png?locale=us)
EMX optioniert seine norwegischen Projekte Sagvoll und Meråker mit mehreren Metallen an Lumira Energy Ltd.
Vancouver (British Columbia), 3. Januar 2024 / IRW-Press / EMX Royalty Corporation (NYSE American: EMX; TSX Venture: EMX; Frankfurt: 6E9) (das „Unternehmen“ oder „EMX“) freut sich, die
![Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXovYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2168a3cbb5338b13f96a4403747baf1bd91ec4f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck030124.001.png?locale=us)
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech
03.01.24
London (www.aktiencheck.de, Anzeige)
Link
![Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKy8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1083dd04e50802d7c4ee68190fa6f0e3a85beb80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg?locale=us)
Analysts suddenly say Google is the place to be in
Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure
![One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOC8rYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3beba95070d9728db8eeac40a7830153fe911810/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg?locale=us)
One fast-food stock is expected to outperform all others in 2024
With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of
![PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1daf898bb8bad1a7a4ebe78b0ad2be44e752c0af/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg?locale=us)
PepsiCo's dividend won't last long in today's market
Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the
![2 gene-editing stocks reshaping hereditary disease treatments: https://www.marketbeat.com/logos/articles/med_20231231121858_chart-ntla.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkgrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d8cf7f26c4d9caf0889b2db456211e7f76836263/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121858_chart-ntla.jpg?locale=us)
2 gene-editing stocks reshaping hereditary disease treatments
Gene-editing companies are making headlines for the potential to reshape the future of healthcare and the treatment of hereditary diseases. The U.S. Federal Drug Administration (FDA) approved a
![4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkwrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1c9cebf72a0f4cd55b634899a8cefacfc3137e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231121354_chart-bros2.jpg?locale=us)
4 reasons to buy Dutch Bros stock over Starbucks
Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO
![New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlArYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07115fedf8efcf6ca8433a73204d56cd8122aa88/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg?locale=us)
New price targets could erase Cisco's 3.1% dividend yield soon
A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you
![Buffett's buy into Sirius XM's short interest, a new sudden rally: https://www.marketbeat.com/logos/articles/med_20240101085309_buffetts-buy-into-sirius-xms-short-interest-a-new.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--99926766864ed0150ef2b497fdc988e228998f67/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240101085309_buffetts-buy-into-sirius-xms-short-interest-a-new.jpg?locale=us)
Buffett's buy into Sirius XM's short interest, a new sudden rally
Only a handful of individuals in history can nod when others advertise them as having a sort of Midas touch, where everything they lay their eyes on seems to turn gold. Warren Buffett can be
![Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEQrYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--162e404cc31f7fcd12195d79f259e53280c66c80/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231231120446_chartt-aapl.jpg?locale=us)
Is the Apple Watch ban the tipping point?
Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have
![3 mega caps with RSIs that point to big Q1s: https://www.marketbeat.com/logos/articles/med_20231229111505_3-mega-caps-with-rsis-that-point-to-big-q1s.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMlA5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c4c52b0d5aea9e2713ff5064fc5c30ab6f776597/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229111505_3-mega-caps-with-rsis-that-point-to-big-q1s.jpg?locale=us)
3 mega caps with RSIs that point to big Q1s
With the S&P 500 index on the verge of hitting an all-time high and many others already there, it's no surprise that investors are enjoying strong year-end rallies. Indeed, all signs point to 2023
![Celsius stock in actionable zone as big investors ramp up buying: https://www.marketbeat.com/logos/articles/med_20231229104624_celsius-stock-in-actionable-zone-as-big-investors.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMTc5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--71de283ce609a124b76dc6923b773c86e4ce5bc1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229104624_celsius-stock-in-actionable-zone-as-big-investors.jpg?locale=us)
Celsius stock in actionable zone as big investors ramp up buying
Energy drink maker Celsius Holdings Inc. (NASDAQ: CELH) has been a fast mover since its 2017 IPO and may offer an early buy opportunity.
The Celsius chart shows the stock consolidating above its
![Microsoft is new cybersecurity titan, challenging big tech rivals: https://www.marketbeat.com/logos/articles/med_20231229082948_microsoft-is-new-cybersecurity-titan-challenging-b.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGo5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e20118b8c529a03f28a3bb79c6424c04bd4b05db/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229082948_microsoft-is-new-cybersecurity-titan-challenging-b.jpg?locale=us)
Microsoft is new cybersecurity titan, challenging big tech rivals
You might not think of Microsoft Corp. (NASDAQ: MSFT) as a leader in the cybersecurity space, but the company has been making big strides in that part of the tech industry.
As with many business
![Synopsys stock: Unsung hero of the AI revolution: https://www.marketbeat.com/logos/articles/med_20231229073521_synopsys-stock-unsung-hero-of-the-ai-revolution.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelg5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6fafaff7c521ba39100a73bf3cadae13645ac976/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229073521_synopsys-stock-unsung-hero-of-the-ai-revolution.jpg?locale=us)
Synopsys stock: Unsung hero of the AI revolution
Synopsys Inc. (NASDAQ: SNPS), maker of semiconductor design software, created a buzz recently when it offered to buy engineering software maker Ansys Inc. (NASDAQ: ANSS).
Synopsys isn’t a
![Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals: https://www.marketbeat.com/logos/articles/med_20231228125224_bristol-myers-squibbs-big-buys-18.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemo5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--172ff16f6c03f3a72068c04d412205991221957b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228125224_bristol-myers-squibbs-big-buys-18.jpg?locale=us)
Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
Bristol Myers Squibb Company (NYSE: BMY) is on a buying spree, announcing two acquisitions in less than a week.
On December 22, the pharma giant said it was acquiring Karuna Therapeutics Inc.
![Apple stock is institutional favorite, but is it overvalued?: https://www.marketbeat.com/logos/articles/med_20231229072720_apple-stock-is-institutional-favorite-but-is-it-ov.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemY5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3ed54ca64d26e9f9b75f8f2a29eb9d03f5765584/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229072720_apple-stock-is-institutional-favorite-but-is-it-ov.jpg?locale=us)
Apple stock is institutional favorite, but is it overvalued?
With Apple Inc. (NASDAQ: AAPL) holding the No. 1 spot as the biggest S&P 500 component, and having posted a 2023 gain of 49.39% is the stock overvalued, or primed for a correction in 2024?
Even
![Four beaten-down penny stocks ready to take off: https://www.marketbeat.com/logos/articles/med_20231228125201_chart-lazr-12282023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUw5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--235d2f6d25f6c1195045857494baccf3be40f8de/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228125201_chart-lazr-12282023ver001.png?locale=us)
Four beaten-down penny stocks ready to take off
Penny stocks are attractive simply because of the opportunity for exponential returns. Stocks like Alphabet Inc. (NASDAQ: GOOG), Microsoft Corporation (NASDAQ: MSFT) and Apple Inc. (NASDAQ: AAPL)
![Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/73132/AC01-29-23_AC1.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0g4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d8ff5dcb07839f213b23490f0422598cb927fee3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC01-29-23_AC1.001.png?locale=us)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Kaufsignal. Diese Biotech-Aktie kaufen nach 15.973% mit BioNTech
29.12.23 08:03
London (www.aktiencheck.de, Anzeige)
![Rivian is all set to start 2024 with a bang: https://www.marketbeat.com/logos/articles/med_20231228084144_rivian-is-all-set-to-start-2024-with-a-bang.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjM4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d138c28d72742f8489b50a35c185646e8814422e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228084144_rivian-is-all-set-to-start-2024-with-a-bang.jpg?locale=us)
Rivian is all set to start 2024 with a bang
As we head into 2024, the electric vehicle (EV) space remains one of the most closely watched by investors. All told it's had a decent year, but one that's far from its best. The Global X
![If you buy the dogs, should you sell these Dow leaders?: https://www.marketbeat.com/logos/articles/med_20231228074608_chart-intc-12282023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjc4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--55601b3b18cc9a888edeb36d42a5a1b380583049/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228074608_chart-intc-12282023ver001.png?locale=us)
If you buy the dogs, should you sell these Dow leaders?
The Dogs of the Dow is a popular strategy getting much attention now that the year-end is here. The theory assumes that this year’s losers will be next year’s winners, which is often true. Dow
![Ray Dalio keeps adding to this ETF, what's he thinking?: https://www.marketbeat.com/logos/articles/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXY4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90be5fd54a0ac7e67a2950b92bfce54c74f46131/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg?locale=us)
Ray Dalio keeps adding to this ETF, what's he thinking?
Last quarter, it became evident to thousands of investors just like you just how bullish Ray Dalio had become on Asian markets. Still, while most thought it was a one-time allocation to gain the
![2 Tech stocks getting bullish upgrades ahead of Q1: https://www.marketbeat.com/logos/articles/med_20231228073315_2-tech-stocks-getting-bullish-upgrades-ahead-of-q1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXI4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e17b42796ac2b21ce345659593b407320e13a3ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228073315_2-tech-stocks-getting-bullish-upgrades-ahead-of-q1.jpg?locale=us)
2 Tech stocks getting bullish upgrades ahead of Q1
There’s no doubt about it: equities have had a super strong end to the year, with the Dow Jones index already at fresh all-time highs and the others on its heels. The benchmark S&P 500 index, for
![Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_de_PRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGI4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--677baaf54c2c4c677a98702f560ff465fc157a28/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NDAAnnualFinancialResults_de_PRcom.001.png?locale=us)
Neptune Digital Assets Corp. veröffentlicht seinen geprüften Finanzbericht: 56 % Plus bei den Mining-Umsätzen und 42 % Plus beim digitalen Währungsguthaben gegenüber dem Vorjahr
VANCOUVER, British Columbia – 28. Dezember 2023 / IRW-Press / – Neptune Digital Assets Corp. (TSX-V: NDA) (OTCQB: NPPTF) (FWB: 1NW) („Neptune“ oder das „Unternehmen“), eines der ersten
![Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year: https://www.irw-press.at/prcom/images/messages/2023/73124/NDAAnnualFinancialResults_en_PRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGY4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b39757ba33334362ea89c1cd477ae88da217453d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NDAAnnualFinancialResults_en_PRcom.001.png?locale=us)
Neptune Digital Assets Corp. Announces the Release of Audited Financial Statements with a 56% Increase in Mining Revenues and 42% Increase in Digital Currency Balances over Prior Year
VANCOUVER, British Columbia – December 28, 2023 – Neptune Digital Assets Corp. (TSX-V:NDA) (OTCQB:NPPTF) (FSE:1NW) (“Neptune” or the "Company"), one of the first publicly traded blockchain